Hymie Anisman - Publications

Carleton University, Ottawa, Canada 

232 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Woods R, McInnis O, Bedard M, Asokumar A, Santoni S, Anisman H, Matheson K, McQuaid RJ. Social support and unsupportive interactions in relation to depressive symptoms: Implication of gender and the BDNF polymorphism. Social Neuroscience. PMID 31364951 DOI: 10.1080/17470919.2019.1650826  0.304
2016 Hayley S, Audet MC, Anisman H. Inflammation and the microbiome: implications for depressive disorders. Current Opinion in Pharmacology. 29: 42-46. PMID 27327647 DOI: 10.1016/J.Coph.2016.06.001  0.6
2016 Clarke M, Razmjou S, Prowse N, Dwyer Z, Litteljohn D, Pentz R, Anisman H, Hayley S. Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changes. Neuropharmacology. PMID 27106168 DOI: 10.1016/j.neuropharm.2016.04.021  0.62
2016 Anisman H. Stress, immunity, cytokines and depression. Acta Neuropsychiatrica. 14: 251-61. PMID 26984573 DOI: 10.1034/j.1601-5215.2002.140601.x  0.308
2016 Anisman H. Stress, immunity, cytokines and depression. Acta Neuropsychiatrica. 14: 251-61. PMID 26984573 DOI: 10.1034/j.1601-5215.2002.140601.x  0.308
2015 Hayley S, Du L, Litteljohn D, Palkovits M, Faludi G, Merali Z, Poulter MO, Anisman H. Gender and brain regions specific differences in brain derived neurotrophic factor protein levels of depressed individuals who died through suicide. Neuroscience Letters. 600: 12-16. PMID 26033186 DOI: 10.1016/J.Neulet.2015.05.052  0.574
2015 McQuaid RJ, Bombay A, McInnis OA, Matheson K, Anisman H. Childhood adversity, perceived discrimination, and coping strategies in relation to depressive symptoms among First Nations adults in Canada: The moderating role of unsupportive social interactions from ingroup and outgroup members. Cultural Diversity & Ethnic Minority Psychology. 21: 326-36. PMID 25090152 DOI: 10.1037/A0037541  0.321
2014 Liu G, Rustom N, Litteljohn D, Bobyn J, Rudyk C, Anisman H, Hayley S. Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology. Frontiers in Cellular Neuroscience. 8: 316. PMID 25352778 DOI: 10.3389/fncel.2014.00316  0.559
2014 Liu G, Anisman H, Bobyn J, Hayley S. Interaction between nonviral reprogrammed fibroblast stem cells and trophic factors for brain repair. Molecular Neurobiology. 50: 673-84. PMID 24677069 DOI: 10.1007/s12035-014-8680-2  0.548
2014 McInnis OA, Matheson K, Anisman H. Living with the unexplained: coping, distress, and depression among women with chronic fatigue syndrome and/or fibromyalgia compared to an autoimmune disorder. Anxiety, Stress, and Coping. 27: 601-18. PMID 24479644 DOI: 10.1080/10615806.2014.888060  0.306
2013 Osborn M, Rustom N, Clarke M, Litteljohn D, Rudyk C, Anisman H, Hayley S. Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes. Plos One. 8: e72813. PMID 24019878 DOI: 10.1371/journal.pone.0072813  0.609
2013 Hayley S, Anisman H. Neurotrophic paths in the treatment of depression. Journal of Psychiatry & Neuroscience : Jpn. 38: 291-3. PMID 23972006 DOI: 10.1503/jpn.130146  0.563
2013 McQuaid RJ, McInnis OA, Stead JD, Matheson K, Anisman H. A paradoxical association of an oxytocin receptor gene polymorphism: early-life adversity and vulnerability to depression. Frontiers in Neuroscience. 7: 128. PMID 23898235 DOI: 10.3389/Fnins.2013.00128  0.304
2013 Caldwell W, McInnis OA, McQuaid RJ, Liu G, Stead JD, Anisman H, Hayley S. The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms. Plos One. 8: e65547. PMID 23824678 DOI: 10.1371/journal.pone.0065547  0.583
2013 Patterson ZR, Khazall R, Mackay H, Anisman H, Abizaid A. Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology. 154: 1080-91. PMID 23341196 DOI: 10.1210/en.2012-1834  0.345
2013 Hayley S, Scharf J, Anisman H. Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments. Brain, Behavior, and Immunity. 31: 115-27. PMID 22884959 DOI: 10.1016/j.bbi.2012.07.023  0.637
2012 Anisman H, Hayley S. Inflammatory factors contribute to depression and its comorbid conditions. Science Signaling. 5: pe45. PMID 23033537 DOI: 10.1126/scisignal.2003579  0.589
2012 Anisman H, Hayley S. Illness comorbidity as a biomarker? Journal of Psychiatry & Neuroscience : Jpn. 37: 221-3. PMID 22709479 DOI: 10.1503/jpn.120092  0.534
2011 Lira A, Kulczycki J, Slack R, Anisman H, Park DS. Involvement of the Fc gamma receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss. The Journal of Biological Chemistry. 286: 28783-93. PMID 21693708 DOI: 10.1074/Jbc.M111.244830  0.324
2011 Audet MC, Jacobson-Pick S, Wann BP, Anisman H. Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges. Brain, Behavior, and Immunity. 25: 1197-205. PMID 21435391 DOI: 10.1016/J.Bbi.2011.03.010  0.355
2011 Gibb J, Hayley S, Poulter MO, Anisman H. Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain, Behavior, and Immunity. 25: 468-82. PMID 21093579 DOI: 10.1016/J.Bbi.2010.11.008  0.632
2010 Poulter MO, Du L, Zhurov V, Palkovits M, Faludi G, Merali Z, Anisman H. Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain. Frontiers in Molecular Neuroscience. 3: 3. PMID 20407580 DOI: 10.3389/Neuro.02.003.2010  0.3
2010 Litteljohn D, Cummings A, Brennan A, Gill A, Chunduri S, Anisman H, Hayley S. Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: Implications for psychological pathology. Brain, Behavior, and Immunity. 24: 462-73. PMID 20004715 DOI: 10.1016/j.bbi.2009.12.001  0.639
2010 Poulter MO, Du L, Zhurov V, Merali Z, Anisman H. Plasticity of the GABA(A) receptor subunit cassette in response to stressors in reactive versus resilient mice. Neuroscience. 165: 1039-51. PMID 19931360 DOI: 10.1016/J.Neuroscience.2009.11.028  0.35
2009 Gibb J, Audet MC, Hayley S, Anisman H. Neurochemical and behavioral responses to inflammatory immune stressors. Frontiers in Bioscience (Scholar Edition). 1: 275-95. PMID 19482702  0.615
2009 Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. Journal of Psychiatry & Neuroscience : Jpn. 34: 4-20. PMID 19125209  0.304
2009 Ysseldyk R, Matheson K, Anisman H. Forgiveness and the appraisal-coping process in response to relationship conflicts: implications for depressive symptoms. Stress (Amsterdam, Netherlands). 12: 152-66. PMID 19096986 DOI: 10.1080/10253890802228178  0.31
2009 Merali Z, Hayley S, Kent P, McIntosh J, Bédard T, Anisman H. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary. Behavioural Brain Research. 198: 105-12. PMID 19014976 DOI: 10.1016/J.Bbr.2008.10.025  0.625
2009 Bombay A, Matheson K, Anisman H. Intergenerational Trauma: Convergence of Multiple Processes among First Nations peoples in Canada International Journal of Indigenous Health. 5: 6-47. DOI: 10.18357/Ijih53200912337  0.324
2008 Mennigen JA, Martyniuk CJ, Crump K, Xiong H, Zhao E, Popesku J, Anisman H, Cossins AR, Xia X, Trudeau VL. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiological Genomics. 35: 273-82. PMID 18765858 DOI: 10.1152/Physiolgenomics.90263.2008  0.332
2008 Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology. 201: 115-23. PMID 18670764 DOI: 10.1007/S00213-008-1252-2  0.341
2008 Merali Z, Anisman H, James JS, Kent P, Schulkin J. Effects of corticosterone on corticotrophin-releasing hormone and gastrin-releasing peptide release in response to an aversive stimulus in two regions of the forebrain (central nucleus of the amygdala and prefrontal cortex). The European Journal of Neuroscience. 28: 165-72. PMID 18662341 DOI: 10.1111/J.1460-9568.2008.06281.X  0.347
2008 Poulter MO, Du L, Weaver IC, Palkovits M, Faludi G, Merali Z, Szyf M, Anisman H. GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biological Psychiatry. 64: 645-52. PMID 18639864 DOI: 10.1016/J.Biopsych.2008.05.028  0.305
2008 Mountney C, Anisman H, Merali Z. Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat. Psychopharmacology. 200: 51-8. PMID 18563394 DOI: 10.1007/S00213-008-1118-7  0.313
2008 Anisman H, Gibb J, Hayley S. Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology. 199: 231-44. PMID 18491079 DOI: 10.1007/s00213-008-1166-z  0.639
2008 Michaud K, Matheson K, Kelly O, Anisman H. Impact of stressors in a natural context on release of cortisol in healthy adult humans: a meta-analysis. Stress (Amsterdam, Netherlands). 11: 177-97. PMID 18465466 DOI: 10.1080/10253890701727874  0.356
2008 Hayley S, Mangano E, Strickland M, Anisman H. Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: divergent actions in cyclooxygenase-2 deficient mice and wild type controls. Journal of Neuroimmunology. 197: 29-36. PMID 18455806 DOI: 10.1016/j.jneuroim.2008.03.015  0.659
2008 Anisman H, Merali Z, Stead JD. Experiential and genetic contributions to depressive- and anxiety-like disorders: clinical and experimental studies. Neuroscience and Biobehavioral Reviews. 32: 1185-206. PMID 18423590 DOI: 10.1016/J.Neubiorev.2008.03.001  0.386
2008 Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Progress in Neurobiology. 85: 1-74. PMID 18346832 DOI: 10.1016/J.Pneurobio.2008.01.004  0.656
2008 Gibb J, Hayley S, Gandhi R, Poulter MO, Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: Circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain, Behavior, and Immunity. 22: 573-89. PMID 18191534 DOI: 10.1016/J.Bbi.2007.12.001  0.669
2008 Matheson K, Jorden S, Anisman H. Relations between trauma experiences and psychological, physical and neuroendocrine functioning among Somali refugees: mediating role of coping with acculturation stressors. Journal of Immigrant and Minority Health / Center For Minority Public Health. 10: 291-304. PMID 17939054 DOI: 10.1007/S10903-007-9086-2  0.318
2008 Wohl MJ, Matheson K, Young MM, Anisman H. Cortisol rise following awakening among problem gamblers: dissociation from comorbid symptoms of depression and impulsivity. Journal of Gambling Studies / Co-Sponsored by the National Council On Problem Gambling and Institute For the Study of Gambling and Commercial Gaming. 24: 79-90. PMID 17891556 DOI: 10.1007/S10899-007-9080-6  0.325
2008 Anisman H, Matheson K, Hayley S. Neurochemical and Transmitter Models of Depression Risk Factors in Depression. 63-90. DOI: 10.1016/B978-0-08-045078-0.00004-6  0.554
2007 Roy V, Merali Z, Poulter MO, Anisman H. Anxiety responses, plasma corticosterone and central monoamine variations elicited by stressors in reactive and nonreactive mice and their reciprocal F1 hybrids. Behavioural Brain Research. 185: 49-58. PMID 17692933 DOI: 10.1016/J.Bbr.2007.07.008  0.354
2007 Anisman H, Prakash P, Merali Z, Poulter MO. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behavioural Brain Research. 181: 180-90. PMID 17517441 DOI: 10.1016/J.Bbr.2007.04.002  0.38
2007 Anisman H, Poulter MO, Gandhi R, Merali Z, Hayley S. Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. Journal of Neuroimmunology. 186: 45-53. PMID 17428549 DOI: 10.1016/J.Jneuroim.2007.02.008  0.671
2007 Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3328-37. PMID 17376993 DOI: 10.1523/Jneurosci.5321-06.2007  0.613
2007 Bédard T, Mountney C, Kent P, Anisman H, Merali Z. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior. Behavioural Brain Research. 179: 133-40. PMID 17335915 DOI: 10.1016/J.Bbr.2007.01.021  0.317
2007 Gandhi R, Hayley S, Gibb J, Merali Z, Anisman H. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain, Behavior, and Immunity. 21: 477-89. PMID 17267173 DOI: 10.1016/J.Bbi.2006.12.005  0.661
2006 Merali Z, Bédard T, Andrews N, Davis B, McKnight AT, Gonzalez MI, Pritchard M, Kent P, Anisman H. Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10387-96. PMID 17035523 DOI: 10.1523/Jneurosci.1219-06.2006  0.305
2006 Mountney C, Sillberg V, Kent P, Anisman H, Merali Z. The role of gastrin-releasing peptide on conditioned fear: differential cortical and amygdaloid responses in the rat. Psychopharmacology. 189: 287-96. PMID 17033843 DOI: 10.1007/S00213-006-0585-Y  0.345
2006 Prakash P, Merali Z, Kolajova M, Tannenbaum BM, Anisman H. Maternal factors and monoamine changes in stress-resilient and susceptible mice: cross-fostering effects. Brain Research. 1111: 122-33. PMID 16876768 DOI: 10.1016/J.Brainres.2006.06.089  0.408
2006 Zhang TY, Bagot R, Parent C, Nesbitt C, Bredy TW, Caldji C, Fish E, Anisman H, Szyf M, Meaney MJ. Maternal programming of defensive responses through sustained effects on gene expression. Biological Psychology. 73: 72-89. PMID 16513241 DOI: 10.1016/J.Biopsycho.2006.01.009  0.301
2006 Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bédard T, Anisman H. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biological Psychiatry. 59: 594-602. PMID 16197926 DOI: 10.1016/J.Biopsych.2005.08.008  0.319
2005 Matheson K, Kelly O, Cole B, Tannenbaum B, Dodd C, Anisman H. Parental bonding and depressive affect: the mediating role of coping resources. The British Journal of Social Psychology / the British Psychological Society. 44: 371-95. PMID 16238845 DOI: 10.1348/014466605X37477  0.324
2005 Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 135: 659-78. PMID 16154288 DOI: 10.1016/J.Neuroscience.2005.03.051  0.662
2005 Anisman H, Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neuroscience and Biobehavioral Reviews. 29: 525-46. PMID 15925696 DOI: 10.1016/J.Neubiorev.2005.03.007  0.391
2005 Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 102: 5215-20. PMID 15784737 DOI: 10.1073/Pnas.0501282102  0.602
2005 Anisman H, Merali Z, Poulter MO, Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Current Pharmaceutical Design. 11: 963-72. PMID 15777247 DOI: 10.2174/1381612053381701  0.668
2005 Hayley S, Anisman H. Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates. Current Pharmaceutical Design. 11: 947-62. PMID 15777246 DOI: 10.2174/1381612053381611  0.64
2004 Sudom K, Turrin NP, Hayley S, Anisman H. Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical change in mice. Neuroimmunomodulation. 11: 341-50. PMID 15316245 DOI: 10.1159/000079415  0.802
2004 Hayley S, Kelly O, Anisman H. Corticosterone changes in response to stressors, acute and protracted actions of tumor necrosis factor-alpha, and lipopolysaccharide treatments in mice lacking the tumor necrosis factor-alpha p55 receptor gene. Neuroimmunomodulation. 11: 241-6. PMID 15249730 DOI: 10.1159/000078442  0.645
2004 Merali Z, Khan S, Michaud DS, Shippy SA, Anisman H. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release. The European Journal of Neuroscience. 20: 229-39. PMID 15245495 DOI: 10.1111/J.1460-9568.2004.03468.X  0.375
2004 Caldji C, Diorio J, Anisman H, Meaney MJ. Maternal behavior regulates benzodiazepine/GABAA receptor subunit expression in brain regions associated with fear in BALB/c and C57BL/6 mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1344-52. PMID 15085086 DOI: 10.1038/sj.npp.1300436  0.351
2004 Merali Z, McIntosh J, Anisman H. Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1409-18. PMID 15039770 DOI: 10.1038/Sj.Npp.1300441  0.313
2004 Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 2045-53. PMID 14985447 DOI: 10.1523/Jneurosci.4564-03.2004  0.626
2004 Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 1478-85. PMID 14960621 DOI: 10.1523/Jneurosci.4734-03.2004  0.309
2003 Merali Z, Michaud D, McIntosh J, Kent P, Anisman H. Differential involvement of amygdaloid CRH system(s) in the salience and valence of the stimuli. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 1201-12. PMID 14659475 DOI: 10.1016/J.Pnpbp.2003.09.014  0.34
2003 Anisman H, Turrin NP, Merali Z, Hayley S. Neurochemical sensitization associated with systemic administration of tumor necrosis factor-alpha: adjuvant action in combination with bovine serum albumin. Journal of Neuroimmunology. 145: 91-102. PMID 14644035 DOI: 10.1016/J.Jneuroim.2003.09.014  0.779
2003 Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, O'Hare MJ, Callaghan S, Slack RS, Przedborski S, Anisman H, Park DS. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 100: 13650-5. PMID 14595022 DOI: 10.1073/Pnas.2232515100  0.586
2003 Matheson K, Anisman H. Systems of coping associated with dysphoria, anxiety and depressive illness: a multivariate profile perspective. Stress (Amsterdam, Netherlands). 6: 223-34. PMID 13129815 DOI: 10.1080/10253890310001594487  0.317
2003 Tannenbaum BM, Tannenbaum GS, Anisman H. Impact of life-long macronutrient choice on neuroendocrine and cognitive functioning in aged mice: differential effects in stressor-reactive and stressor-resilient mouse strains. Brain Research. 985: 187-97. PMID 12967723 DOI: 10.1016/S0006-8993(03)03196-2  0.324
2003 Merali Z, Levac C, Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biological Psychiatry. 54: 552-65. PMID 12946884 DOI: 10.1016/S0006-3223(02)01827-9  0.361
2003 Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4081-91. PMID 12764095 DOI: 10.1523/Jneurosci.23-10-04081.2003  0.595
2003 Michaud DS, McLean J, Keith SE, Ferrarotto C, Hayley S, Khan SA, Anisman H, Merali Z. Differential impact of audiogenic stressors on Lewis and Fischer rats: behavioral, neurochemical, and endocrine variations. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1068-81. PMID 12700709 DOI: 10.1038/Sj.Npp.1300149  0.616
2003 Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Annals of Medicine. 35: 2-11. PMID 12693607 DOI: 10.1080/07853890310004075  0.305
2003 Anisman H, Merali Z, Hayley S. Sensitization associated with stressors and cytokine treatments. Brain, Behavior, and Immunity. 17: 86-93. PMID 12676571 DOI: 10.1016/S0889-1591(02)00100-9  0.653
2003 Crocker SJ, Liston P, Anisman H, Lee CJ, Smith PD, Earl N, Thompson CS, Park DS, Korneluk RG, Robertson GS. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiology of Disease. 12: 150-61. PMID 12667469 DOI: 10.1016/S0969-9961(02)00020-7  0.321
2003 Hayley S, Merali Z, Anisman H. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress (Amsterdam, Netherlands). 6: 19-32. PMID 12637204 DOI: 10.1080/1025389031000091167  0.69
2003 Tannenbaum B, Anisman H. Impact of chronic intermittent challenges in stressor-susceptible and resilient strains of mice. Biological Psychiatry. 53: 292-303. PMID 12586448 DOI: 10.1016/S0006-3223(02)01487-7  0.382
2002 Hayley S, Merali Z, Anisman H. The acute and sensitization effects of tumor necrosis factor-α: implications for immunotherapy as well as psychiatric and neurological conditions. Acta Neuropsychiatrica. 14: 322-35. PMID 26984578 DOI: 10.1034/j.1601-5215.2002.140606.x  0.654
2002 Anisman H, Hayley S, Turrin N, Merali Z. Cytokines as a stressor: implications for depressive illness. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 5: 357-73. PMID 12466035 DOI: 10.1017/S1461145702003097  0.81
2002 Hayley S, Kelly O, Anisman H. Murine tumor necrosis factor-alpha sensitizes plasma corticosterone activity and the manifestation of shock: modulation by histamine. Journal of Neuroimmunology. 131: 60-9. PMID 12458037 DOI: 10.1016/S0165-5728(02)00259-X  0.627
2002 Anisman H, Kokkinidis L, Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain, Behavior, and Immunity. 16: 544-56. PMID 12401468 DOI: 10.1016/S0889-1591(02)00011-9  0.394
2002 Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain, Behavior, and Immunity. 16: 513-24. PMID 12401465 DOI: 10.1016/S0889-1591(02)00009-0  0.379
2002 Tannenbaum B, Tannenbaum GS, Sudom K, Anisman H. Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Research. 953: 82-92. PMID 12384241 DOI: 10.1016/S0006-8993(02)03273-0  0.438
2002 Ravindran AV, Matheson K, Griffiths J, Merali Z, Anisman H. Stress, coping, uplifts, and quality of life in subtypes of depression: a conceptual frame and emerging data. Journal of Affective Disorders. 71: 121-30. PMID 12167508 DOI: 10.1016/S0165-0327(01)00389-5  0.326
2002 Hayley S, Wall P, Anisman H. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms. The European Journal of Neuroscience. 15: 1061-76. PMID 11918665 DOI: 10.1046/j.1460-9568.2002.01936.x  0.637
2002 Merali Z, Kent P, Anisman H. Role of bombesin-related peptides in the mediation or integration of the stress response. Cellular and Molecular Life Sciences : Cmls. 59: 272-87. PMID 11915944 DOI: 10.1007/S00018-002-8422-X  0.324
2002 Hayley S, Merali Z, Anisman H. The acute and sensitization effects of tumor necrosis factor-α: Implications for immunotherapy as well as psychiatric and neurological conditions Acta Neuropsychiatrica. 14: 322-335. DOI: 10.1034/j.1601-5215.2002.140606.x  0.548
2001 Anisman H, Merali Z. Rodent models of depression: learned helplessness induced in mice. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.10C. PMID 18428538 DOI: 10.1002/0471142301.Ns0810Cs14  0.376
2001 Hayley S, Staines W, Merali Z, Anisman H. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha. Neuroscience. 106: 137-48. PMID 11564424 DOI: 10.1016/S0306-4522(01)00276-7  0.65
2001 Merali Z, Kent P, Michaud D, McIntyre D, Anisman H. Differential impact of predator or immobilization stressors on central corticotropin-releasing hormone and bombesin-like peptides in Fast and Slow seizing rat. Brain Research. 906: 60-73. PMID 11430862 DOI: 10.1016/S0006-8993(01)02556-2  0.313
2001 Anisman H, Hayley S, Kelly O, Borowski T, Merali Z. Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behavioral Neuroscience. 115: 443-54. PMID 11345969 DOI: 10.1037/0735-7044.115.2.443  0.643
2001 Hayley S, Lacosta S, Merali Z, van Rooijen N, Anisman H. Central monoamine and plasma corticosterone changes induced by a bacterial endotoxin: sensitization and cross-sensitization effects. The European Journal of Neuroscience. 13: 1155-65. PMID 11285013 DOI: 10.1046/J.0953-816X.2001.01496.X  0.664
2001 Kent P, Bédard T, Khan S, Anisman H, Merali Z. Bombesin-induced HPA and sympathetic activation requires CRH receptors. Peptides. 22: 57-65. PMID 11179598 DOI: 10.1016/S0196-9781(00)00355-7  0.322
2001 Hayley S, Borowski T, Merali Z, Anisman H. Central monoamine activity in genetically distinct strains of mice following a psychogenic stressor: effects of predator exposure. Brain Research. 892: 293-300. PMID 11172776 DOI: 10.1016/S0006-8993(00)03262-5  0.646
2001 Anisman H, Hayley S, Merali Z. Behavioral and central neurochemical consequences of cytokine challenge: Relationship to stressors Neuroimmune Biology. 1: 141-161. DOI: 10.1016/S1567-7443(01)80014-4  0.679
2000 Anisman H, Kelly O, Hayley S, Borowski T, Merali Z, McIntyre DC. Acoustic startle and fear-potentiated startle in rats selectively bred for fast and slow kindling rates: relation to monoamine activity. The European Journal of Neuroscience. 12: 4405-16. PMID 11122351 DOI: 10.1046/J.0953-816X.2000.01216.X  0.608
2000 Lacosta S, Merali Z, Anisman H. Central monoamine activity following acute and repeated systemic interleukin-2 administration. Neuroimmunomodulation. 8: 83-90. PMID 10965233 DOI: 10.1159/000026457  0.375
2000 Griffiths J, Ravindran AV, Merali Z, Anisman H. Dysthymia: a review of pharmacological and behavioral factors. Molecular Psychiatry. 5: 242-61. PMID 10889527 DOI: 10.1038/Sj.Mp.4000697  0.369
2000 Pu S, Anisman H, Merali Z. Central infusion of interleukin-1 receptor antagonist fails to alter feeding and weight gain. Neuroreport. 11: 1699-702. PMID 10852228 DOI: 10.1097/00001756-200006050-00021  0.306
2000 Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 566-80. PMID 10788757 DOI: 10.1016/S0893-133X(99)00166-9  0.653
2000 Zaharia MD, Ravindran AV, Griffiths J, Merali Z, Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. Journal of Affective Disorders. 58: 1-10. PMID 10760553 DOI: 10.1016/S0165-0327(99)00100-7  0.334
2000 Lacey K, Zaharia MD, Griffiths J, Ravindran AV, Merali Z, Anisman H. A prospective study of neuroendocrine and immune alterations associated with the stress of an oral academic examination among graduate students. Psychoneuroendocrinology. 25: 339-56. PMID 10725611 DOI: 10.1016/S0306-4530(99)00059-1  0.347
2000 Plata-Salamán CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Bedard T, Merali Z, Anisman H. Neither acute nor chronic exposure to a naturalistic (predator) stressor influences the interleukin-1beta system, tumor necrosis factor-alpha, transforming growth factor-beta1, and neuropeptide mRNAs in specific brain regions. Brain Research Bulletin. 51: 187-93. PMID 10709966 DOI: 10.1016/S0361-9230(99)00204-X  0.789
2000 Plata-Salamán CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Romanovitch AE, Kelly ME, Bureau Y, Anisman H, McIntyre DC. Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Research. Molecular Brain Research. 75: 248-58. PMID 10686345 DOI: 10.1016/S0169-328X(99)00306-X  0.771
1999 Lu ZW, Hayley S, Ravindran AV, Merali Z, Anisman H. Influence of psychosocial, psychogenic and neurogenic stressors on several aspects of immune functioning in mice. Stress (Amsterdam, Netherlands). 3: 55-70. PMID 19016193 DOI: 10.3109/10253899909001112  0.6
1999 Anisman H, Ravindran AV, Griffiths J, Merali Z. Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biological Psychiatry. 46: 1649-55. PMID 10624546 DOI: 10.1016/S0006-3223(99)00211-5  0.318
1999 Lacosta S, Merali Z, Anisman H. Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behavioral Neuroscience. 113: 1030-41. PMID 10571485 DOI: 10.1037//0735-7044.113.5.1030  0.359
1999 McIntyre DC, Kent P, Hayley S, Merali Z, Anisman H. Influence of psychogenic and neurogenic stressors on neuroendocrine and central monoamine activity in fast and slow kindling rats. Brain Research. 840: 65-74. PMID 10517953 DOI: 10.1016/S0006-8993(99)01771-0  0.627
1999 Khan S, Michaud D, Moody TW, Anisman H, Merali Z. Effects of acute restraint stress on endogenous adrenomedullin levels. Neuroreport. 10: 2829-33. PMID 10511448 DOI: 10.1097/00001756-199909090-00024  0.345
1999 Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Advances in Experimental Medicine and Biology. 461: 199-233. PMID 10442175 DOI: 10.1007/978-0-585-37970-8_12  0.392
1999 Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5654-65. PMID 10377371  0.633
1999 Song C, Merali Z, Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 88: 823-36. PMID 10363820 DOI: 10.1016/S0306-4522(98)00271-1  0.403
1999 Michaud D, Anisman H, Merali Z. Capsaicin-sensitive fibers are required for the anorexic action of systemic but not central bombesin. The American Journal of Physiology. 276: R1617-22. PMID 10362739 DOI: 10.1152/Ajpregu.1999.276.6.R1617  0.306
1999 Ravindran AV, Griffiths J, Merali Z, Anisman H. Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. Journal of Affective Disorders. 52: 1-10. PMID 10357012 DOI: 10.1016/S0165-0327(98)00072-X  0.34
1999 Connor TJ, Song C, Leonard BE, Anisman H, Merali Z. Stressor-induced alterations in serotonergic activity in an animal model of depression. Neuroreport. 10: 523-8. PMID 10208583 DOI: 10.1097/00001756-199902250-00015  0.354
1999 Ravindran AV, Griffiths J, Merali Z, Knott VJ, Anisman H. Influence of acute tryptophan depletion on mood and immune measures in healthy males. Psychoneuroendocrinology. 24: 99-113. PMID 10098222 DOI: 10.1016/S0306-4530(98)00040-7  0.368
1999 Lacosta S, Merali Z, Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Research. 818: 291-303. PMID 10082815 DOI: 10.1016/S0006-8993(98)01288-8  0.38
1999 Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H. Sensitization to the Effects of Tumor Necrosis Factor-α: Neuroendocrine, Central Monoamine, and Behavioral Variations The Journal of Neuroscience. 19: 5654-5665. DOI: 10.1523/Jneurosci.19-13-05654.1999  0.388
1998 Borowski T, Kokkinidis L, Merali Z, Anisman H. Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport. 9: 3797-802. PMID 9875707 DOI: 10.1097/00001756-199812010-00006  0.363
1998 Anisman H, Lacosta S, Kent P, McIntyre DC, Merali Z. Stressor-induced corticotropin-releasing hormone, bombesin, ACTH and corticosterone variations in strains of mice differentially responsive to stressors. Stress (Amsterdam, Netherlands). 2: 209-20. PMID 9787268 DOI: 10.3109/10253899809167284  0.371
1998 Anisman H, Zaharia MD, Meaney MJ, Merali Z. Do early-life events permanently alter behavioral and hormonal responses to stressors? International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 149-64. PMID 9785112 DOI: 10.1016/S0736-5748(98)00025-2  0.393
1998 Lacosta S, Merali Z, Anisman H. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology. 137: 351-61. PMID 9676895 DOI: 10.1007/s002130050630  0.381
1998 Ravindran AV, Griffiths J, Merali Z, Anisman H. Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features. Psychosomatic Medicine. 60: 283-9. PMID 9625215 DOI: 10.1097/00006842-199805000-00013  0.307
1998 Merali Z, McIntosh J, Kent P, Michaud D, Anisman H. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 4758-66. PMID 9614249 DOI: 10.1523/Jneurosci.18-12-04758.1998  0.318
1998 Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84: 923-33. PMID 9579794 DOI: 10.1016/S0306-4522(97)00533-2  0.417
1998 Lu ZW, Song C, Ravindran AV, Merali Z, Anisman H. Influence of a psychogenic and a neurogenic stressor on several indices of immune functioning in different strains of mice. Brain, Behavior, and Immunity. 12: 7-22. PMID 9570858 DOI: 10.1006/brbi.1997.0510  0.343
1998 Hebb AL, Zacharko RM, Anisman H. Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration. Brain Research Bulletin. 45: 549-56. PMID 9566497 DOI: 10.1016/S0361-9230(97)00447-4  0.322
1998 Kent P, Anisman H, Merali Z. Are bombesin-like peptides involved in the mediation of stress response? Life Sciences. 62: 103-14. PMID 9488109 DOI: 10.1016/S0024-3205(97)01057-6  0.348
1998 Anisman H, Kokkinidis L, Borowski T, Merali Z. Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Research. 779: 177-87. PMID 9473665 DOI: 10.1016/S0006-8993(97)01114-1  0.349
1997 Anisman H, Merali Z. Chronic stressors and depression: distinguishing characteristics and individual profiles. Psychopharmacology. 134: 330-2; discussion 37. PMID 9452164 DOI: 10.1007/s002130050457  0.303
1997 Zacharko RM, Zalcman S, Macneil G, Andrews M, Mendella PD, Anisman H. Differential effects of immunologic challenge on self-stimulation from the nucleus accumbens and the substantia nigra. Pharmacology, Biochemistry, and Behavior. 58: 881-6. PMID 9408190 DOI: 10.1016/S0091-3057(97)00053-1  0.343
1997 Merali Z, Lacosta S, Anisman H. Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Research. 761: 225-35. PMID 9252020 DOI: 10.1016/S0006-8993(97)00312-0  0.409
1997 Griffiths J, Ravindran AV, Merali Z, Anisman H. Neuroendocrine measures and lymphocyte subsets in depressive illness: influence of a clinical interview concerning life experiences. Psychoneuroendocrinology. 22: 225-36. PMID 9226727 DOI: 10.1016/S0306-4530(97)00025-5  0.346
1997 Anisman H, Lu ZW, Song C, Kent P, McIntyre DC, Merali Z. Influence of psychogenic and neurogenic stressors on endocrine and immune activity: differential effects in fast and slow seizing rat strains. Brain, Behavior, and Immunity. 11: 63-74. PMID 9193768 DOI: 10.1006/Brbi.1997.0482  0.331
1997 Ravindran A, Griffiths J, Zaharia M, Merali Z, Anisman H. Immune & endocrine alterations in atypical depression Biological Psychiatry. 42: 114S. DOI: 10.1016/S0006-3223(97)87371-4  0.311
1996 Ravindran AV, Griffiths J, Merali Z, Anisman H. Variations of lymphocyte subsets associated with stress in depressive populations. Psychoneuroendocrinology. 21: 659-71. PMID 9247985 DOI: 10.1016/S0306-4530(96)00030-3  0.348
1996 Zaharia MD, Kulczycki J, Shanks N, Meaney MJ, Anisman H. The effects of early postnatal stimulation on Morris water-maze acquisition in adult mice: genetic and maternal factors. Psychopharmacology. 128: 227-39. PMID 8972542 DOI: 10.1007/s002130050130  0.361
1996 Anisman H, Kokkinidis L, Merali Z. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Research. 731: 1-11. PMID 8883848 DOI: 10.1016/0006-8993(96)00460-X  0.367
1996 Ravindran AV, Griffiths J, Merali Z, Anisman H. Primary dysthymia: a study of several psychosocial, endocrine and immune correlates. Journal of Affective Disorders. 40: 73-84. PMID 8882917 DOI: 10.1016/0165-0327(96)00045-6  0.36
1996 Kerr L, Drummond L, Zaharia M, Clelford J, Anisman H. Stressor-induced alterations of the splenic plaque-forming cell response: strain differences and modification by propranolol. Pharmacology, Biochemistry, and Behavior. 53: 235-41. PMID 8808126 DOI: 10.1016/0091-3057(95)00201-4  0.342
1995 Ravindran AV, Griffiths J, Waddell C, Anisman H. Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 19: 637-53. PMID 8588062 DOI: 10.1016/0278-5846(95)00108-8  0.334
1995 Francis DD, Zaharia MD, Shanks N, Anisman H. Stress-induced disturbances in Morris water-maze performance: interstrain variability. Physiology & Behavior. 58: 57-65. PMID 7667428 DOI: 10.1016/0031-9384(95)00009-8  0.644
1994 Shanks N, Renton C, Zalcman S, Anisman H. Influence of change from grouped to individual housing on a T-cell-dependent immune response in mice: antagonism by diazepam. Pharmacology, Biochemistry, and Behavior. 47: 497-502. PMID 8208767 DOI: 10.1016/0091-3057(94)90150-3  0.312
1994 Shanks N, Griffiths J, Anisman H. Central catecholamine alterations induced by stressor exposure: analyses in recombinant inbred strains of mice. Behavioural Brain Research. 63: 25-33. PMID 7945974 DOI: 10.1016/0166-4328(94)90047-7  0.362
1994 Lacosta S, Merali Z, Zalcman S, Anisman H. Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge. Brain Research. 664: 225-30. PMID 7895033 DOI: 10.1016/0006-8993(94)91976-3  0.353
1994 Shanks N, Francis D, Zalcman S, Meaney MJ, Anisman H. Alterations in central catecholamines associated with immune responding in adult and aged mice. Brain Research. 666: 77-87. PMID 7889370 DOI: 10.1016/0006-8993(94)90284-4  0.654
1994 Shanks N, Griffiths J, Anisman H. Norepinephrine and serotonin alterations following chronic stressor exposure: mouse strain differences. Pharmacology, Biochemistry, and Behavior. 49: 57-65. PMID 7816890 DOI: 10.1016/0091-3057(94)90456-1  0.382
1994 Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Research. 643: 40-9. PMID 7518332 DOI: 10.1016/0006-8993(94)90006-X  0.359
1993 Shanks N, Anisman H. Escape deficits induced by uncontrollable foot-shock in recombinant inbred strains of mice. Pharmacology, Biochemistry, and Behavior. 46: 511-7. PMID 8278427 DOI: 10.1016/0091-3057(93)90538-5  0.314
1993 Zalcman S, Anisman H. Acute and chronic stressor effects on the antibody response to sheep red blood cells. Pharmacology, Biochemistry, and Behavior. 46: 445-52. PMID 8265700 DOI: 10.1016/0091-3057(93)90377-6  0.355
1993 Anisman H, Zalcman S, Zacharko RM. The impact of stressors on immune and central neurotransmitter activity: bidirectional communication. Reviews in the Neurosciences. 4: 147-80. PMID 7952386 DOI: 10.1515/REVNEURO.1993.4.2.147  0.339
1992 Anisman H, Zacharko RM. Resistance to stress: multiple neurochemical, behavioral and genetic factors. Journal of Psychopharmacology (Oxford, England). 6: 8-10. PMID 22291234 DOI: 10.1177/026988119200600103  0.321
1992 Griffiths J, Shanks N, Anisman H. Strain-specific alterations in consumption of a palatable diet following repeated stressor exposure. Pharmacology, Biochemistry, and Behavior. 42: 219-27. PMID 1631180 DOI: 10.1016/0091-3057(92)90519-L  0.321
1992 Anisman H, Zacharko RM. Depression as a consequence of inadequate neurochemical adaptation in response to stressors. The British Journal of Psychiatry. Supplement. 36-43. PMID 1356356 DOI: 10.1192/S0007125000296669  0.342
1991 Shanks N, Zalcman S, Zacharko RM, Anisman H. Alterations of central norepinephrine, dopamine and serotonin in several strains of mice following acute stressor exposure. Pharmacology, Biochemistry, and Behavior. 38: 69-75. PMID 2017456 DOI: 10.1016/0091-3057(91)90591-O  0.356
1991 Zacharko RM, Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neuroscience and Biobehavioral Reviews. 15: 391-405. PMID 1956607 DOI: 10.1016/S0149-7634(05)80032-6  0.375
1991 Zalcman S, Kerr L, Anisman H. Immunosuppression elicited by stressors and stressor-related odors. Brain, Behavior, and Immunity. 5: 262-73. PMID 1954403 DOI: 10.1016/0889-1591(91)90022-3  0.322
1991 Zalcman S, Irwin J, Anisman H. Stressor-induced alterations of natural killer cell activity and central catecholamines in mice. Pharmacology, Biochemistry, and Behavior. 39: 361-6. PMID 1946577 DOI: 10.1016/0091-3057(91)90192-5  0.531
1991 Zalcman S, Henderson N, Richter M, Anisman H. Age-related enhancement and suppression of a T-cell-dependent antibody response following stressor exposure. Behavioral Neuroscience. 105: 669-76. PMID 1815618 DOI: 10.1037/0735-7044.105.5.669  0.343
1991 Zalcman S, Shanks N, Anisman H. Time-dependent variations of central norepinephrine and dopamine following antigen administration. Brain Research. 557: 69-76. PMID 1747770 DOI: 10.1016/0006-8993(91)90117-E  0.343
1990 Shanks N, Griffiths J, Zalcman S, Zacharko RM, Anisman H. Mouse strain differences in plasma corticosterone following uncontrollable footshock. Pharmacology, Biochemistry, and Behavior. 36: 515-9. PMID 2377652 DOI: 10.1016/0091-3057(90)90249-H  0.329
1990 Zacharko RM, Kasian M, Irwin J, Zalcman S, LaLonde G, MacNeil G, Anisman H. Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain. Behavioural Brain Research. 36: 251-81. PMID 2310489 DOI: 10.1016/0166-4328(90)90062-J  0.518
1990 Zacharko RM, Gilmore W, MacNeil G, Kasian M, Anisman H. Stressor induced variations of intracranial self-stimulation from the mesocortex in several strains of mice. Brain Research. 533: 353-7. PMID 2289151 DOI: 10.1016/0006-8993(90)91363-L  0.33
1990 Zacharko RM, Kasian M, MacNeil G, Anisman H. Stressor-induced behavioral alterations in intracranial self-stimulation from the ventral tegmental area: evidence for regional variations. Brain Research Bulletin. 25: 617-21. PMID 2271965 DOI: 10.1016/0361-9230(90)90122-G  0.327
1990 Anisman H, Zacharko RM. Multiple neurochemical and behavioral consequences of stressors: implications for depression. Pharmacology & Therapeutics. 46: 119-36. PMID 2181488 DOI: 10.1016/0163-7258(90)90039-5  0.36
1990 Prince CR, Anisman H. Situation specific effects of stressor controllability on plasma corticosterone changes in mice. Pharmacology, Biochemistry, and Behavior. 37: 613-21. PMID 2093165 DOI: 10.1016/0091-3057(90)90535-P  0.344
1989 Zalcman S, Richter M, Anisman H. Alterations of immune functioning following exposure to stressor-related cues. Brain, Behavior, and Immunity. 3: 99-109. PMID 2790233 DOI: 10.1016/0889-1591(89)90010-X  0.343
1989 Shanks N, Anisman H. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock. Psychopharmacology. 99: 122-8. PMID 2506597 DOI: 10.1007/BF00634465  0.334
1988 Shanks N, Anisman H. Stressor-provoked behavioral changes in six strains of mice. Behavioral Neuroscience. 102: 894-905. PMID 3214540 DOI: 10.1037/0735-7044.102.6.894  0.357
1988 Zalcman S, Minkiewicz-Janda A, Richter M, Anisman H. Critical periods associated with stressor effects on antibody titers and on the plaque-forming cell response to sheep red blood cells. Brain, Behavior, and Immunity. 2: 254-66. PMID 3072030 DOI: 10.1016/0889-1591(88)90027-X  0.333
1987 Zacharko RM, Lalonde GT, Kasian M, Anisman H. Strain-specific effects of inescapable shock on intracranial self-stimulation from the nucleus accumbens. Brain Research. 426: 164-8. PMID 3690312 DOI: 10.1016/0006-8993(87)90436-7  0.329
1987 Anisman H, Irwin J, Bowers W, Ahluwalia P, Zacharko RM. Variations of norepinephrine concentrations following chronic stressor application. Pharmacology, Biochemistry, and Behavior. 26: 653-9. PMID 3602027 DOI: 10.1016/0091-3057(87)90592-2  0.544
1986 Prince CR, Collins C, Anisman H. Stressor-provoked response patterns in a swim task: modification by diazepam. Pharmacology, Biochemistry, and Behavior. 24: 323-8. PMID 3952121 DOI: 10.1016/0091-3057(86)90359-X  0.362
1986 Hahn B, Zacharko RM, Anisman H. Alterations of amphetamine elicited perseveration and locomotor excitation following acute and repeated stressor application. Pharmacology, Biochemistry, and Behavior. 25: 29-33. PMID 3749234 DOI: 10.1016/0091-3057(86)90225-X  0.337
1986 Irwin J, Ahluwalia P, Anisman H. Sensitization of norepinephrine activity following acute and chronic footshock. Brain Research. 379: 98-103. PMID 3742219 DOI: 10.1016/0006-8993(86)90260-X  0.539
1986 Irwin J, Ahluwalia P, Zacharko RM, Anisman H. Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling. Pharmacology, Biochemistry, and Behavior. 24: 1151-4. PMID 3714773 DOI: 10.1016/0091-3057(86)90471-5  0.534
1986 Kokkinidis L, Zacharko RM, Anisman H. Amphetamine withdrawal: a behavioral evaluation. Life Sciences. 38: 1617-23. PMID 3702594 DOI: 10.1016/0024-3205(86)90501-1  0.339
1986 Anisman H, Zacharko RM. Behavioral and neurochemical consequences associated with stressors. Annals of the New York Academy of Sciences. 467: 205-25. PMID 3524379 DOI: 10.1111/J.1749-6632.1986.Tb14630.X  0.374
1985 Anisman H, Hahn B, Hoffman D, Zacharko RM. Stressor invoked exacerbation of amphetamine-elicited perseveration. Pharmacology, Biochemistry, and Behavior. 23: 173-83. PMID 4059303 DOI: 10.1016/0091-3057(85)90552-0  0.33
1985 Szostak C, Anisman H. Stimulus perseveration in a water maze following exposure to controllable and uncontrollable shock. Behavioral and Neural Biology. 43: 178-98. PMID 4004688 DOI: 10.1016/S0163-1047(85)91357-3  0.339
1985 Bowers W, Hamilton M, Zacharko RM, Anisman H. Differential effects of pimozide on response-rate and choice accuracy in a self-stimulation paradigm in mice. Pharmacology, Biochemistry, and Behavior. 22: 521-6. PMID 2859610 DOI: 10.1016/0091-3057(85)90268-0  0.318
1984 Zacharko RM, Bowers WJ, Anisman H. Responding for brain stimulation: stress and desmethylimipramine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 8: 601-6. PMID 6543396 DOI: 10.1016/0278-5846(84)90021-6  0.383
1984 Prince CR, Anisman H. Acute and chronic stress effects on performance in a forced-swim task. Behavioral and Neural Biology. 42: 99-119. PMID 6543117 DOI: 10.1016/S0163-1047(84)90942-7  0.403
1984 Zacharko RM, Bowers WJ, Kelley MS, Anisman H. Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine. Brain Research. 321: 175-9. PMID 6541958 DOI: 10.1016/0006-8993(84)90697-8  0.371
1984 Bruto V, Beauchamp C, Zacharko RM, Anisman H. Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment. Psychopharmacology. 83: 62-9. PMID 6429702 DOI: 10.1007/Bf00427424  0.378
1984 Anisman H, Beauchamp C, Zacharko RM. Effects of inescapable shock and norepinephrine depletion induced by DSP4 on escape performance. Psychopharmacology. 83: 56-61. PMID 6429701 DOI: 10.1007/BF00427423  0.406
1983 Irwin J, Tombaugh TN, Zacharko RM, Anisman H. Alteration of exploration and the response to food associated cues after treatment with pimozide. Pharmacology, Biochemistry, and Behavior. 18: 235-46. PMID 6835981 DOI: 10.1016/0091-3057(83)90369-6  0.488
1983 Bruto V, Anisman H. Alterations of exploratory patterns induced by uncontrollable shock. Behavioral and Neural Biology. 37: 302-16. PMID 6684913 DOI: 10.1016/S0163-1047(83)91368-7  0.35
1983 Anisman H, Irwin J, Beauchamp C, Zacharko R. Cross-stressor immunization against the behavioral deficits introduced by uncontrollable shock. Behavioral Neuroscience. 97: 452-61. PMID 6683562 DOI: 10.1037//0735-7044.97.3.452  0.505
1983 Bruto V, Kokkinidis L, Anisman H. Attenuation of perseverative behavior after repeated amphetamine treatment: tolerance or attentional deficits? Pharmacology, Biochemistry, and Behavior. 19: 497-504. PMID 6634901 DOI: 10.1016/0091-3057(83)90126-0  0.339
1983 Bruto V, Anisman H. Acute and chronic amphetamine treatment: differential modification of exploratory behavior in a radial maze. Pharmacology, Biochemistry, and Behavior. 19: 487-96. PMID 6634900 DOI: 10.1016/0091-3057(83)90125-9  0.335
1983 Zacharko RM, Bowers WJ, Kokkinidis L, Anisman H. Region-specific reductions of intracranial self-stimulation after uncontrollable stress: possible effects on reward processes. Behavioural Brain Research. 9: 129-41. PMID 6603854 DOI: 10.1016/0166-4328(83)90123-7  0.345
1982 Anisman H, Irwin J, Zacharko RM, Tombaugh TN. Effects of dopamine receptor blockade on avoidance performance: assessment of effects on cue-shock and response-outcome associations. Behavioral and Neural Biology. 36: 280-90. PMID 7183319 DOI: 10.1016/S0163-1047(82)90903-7  0.537
1982 Anisman H, Corradini A, Tombaugh TN, Zacharko RM. Avoidance performance, cue and response-choice discrimination after neuroleptic treatment. Pharmacology, Biochemistry, and Behavior. 17: 1245-9. PMID 7163355 DOI: 10.1016/0091-3057(82)90128-9  0.329
1982 Anisman H, Zacharko RM. Stimulus change influences escape performance: deficits induced by uncontrollable stress and by haloperidol. Pharmacology, Biochemistry, and Behavior. 17: 263-9. PMID 6890209 DOI: 10.1016/0091-3057(82)90080-6  0.353
1982 Anisman H, Zacharko RM. Depression: The predisposing influence of stress Behavioral and Brain Sciences. 5: 89-99. DOI: 10.1017/S0140525X00010633  0.386
1981 Anisman H, Sklar LS. Social housing conditions influence escape deficits produced by uncontrollable stress: assessment of the contribution of norepinephrine. Behavioral and Neural Biology. 32: 406-27. PMID 7283930 DOI: 10.1016/S0163-1047(81)90839-6  0.376
1981 Kokkinidis L, Anisman H. Amphetamine psychosis and schizophrenia: a dual model. Neuroscience and Biobehavioral Reviews. 5: 449-61. PMID 7033842 DOI: 10.1016/0149-7634(81)90015-4  0.319
1981 Sklar LS, Bruto V, Anisman H. Adaptation to the tumor-enhancing effects of stress. Psychosomatic Medicine. 43: 331-42. PMID 6792649 DOI: 10.1097/00006842-198108000-00006  0.309
1981 Anisman H, Ritch M, Sklar LS. Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects. Psychopharmacology. 74: 263-8. PMID 6791235 DOI: 10.1007/BF00427107  0.336
1981 Anisman H, Glazier SJ, Sklar LS. Cholinergic influences on escape deficits produced by uncontrollable stress. Psychopharmacology. 74: 81-7. PMID 6791211 DOI: 10.1007/BF00431762  0.331
1980 Irwin J, Suissa A, Anisman H. Differential effects of inescapable shock on escape performance and discrimination learning in a water escape task. Journal of Experimental Psychology. Animal Behavior Processes. 6: 21-40. PMID 7373225 DOI: 10.1037//0097-7403.6.1.21  0.492
1980 Anisman H, Suissa A, Sklar LS. Escape deficits induced by uncontrollable stress: antagonism by dopamine and norepinephrine agonists. Behavioral and Neural Biology. 28: 34-47. PMID 7352925 DOI: 10.1016/S0163-1047(80)93132-5  0.325
1980 Tombaugh TN, Anisman H, Tombaugh J. Extinction and dopamine receptor blockade after intermittent reinforcement training: failure to observe functional equivalence. Psychopharmacology. 70: 19-28. PMID 6775330 DOI: 10.1007/BF00432365  0.307
1979 Kokkinidis L, Irwin J, Anisman H. Ontogenetic variations in amphetamine-induced stimulus perseveration. Behavioral and Neural Biology. 26: 221-33. PMID 573999 DOI: 10.1016/S0163-1047(79)92627-X  0.535
1979 Anisman H, Sklar LS. Catecholamine depletion in mice upon reexposure to stress: mediation of the escape deficits produced by inescapable shock. Journal of Comparative and Physiological Psychology. 93: 610-25. PMID 573289 DOI: 10.1037/h0077603  0.397
1979 Anisman H, Grimmer L, Irwin J, Remington G, Sklar LS. Escape performance after inescapable shock in selectively bred lines of mice: response maintenance and catecholamine activity. Journal of Comparative and Physiological Psychology. 93: 229-41. PMID 457947 DOI: 10.1037/H0077557  0.524
1979 Anisman H, Irwin J, Sklar LS. Deficits of escape performance following catecholamine depletion: implications for behavioral deficits induced by uncontrollable stress. Psychopharmacology. 64: 163-70. PMID 115036 DOI: 10.1007/Bf00496057  0.573
1979 Kokkinidis L, Anisman H. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement. Psychopharmacology. 64: 45-54. PMID 113831 DOI: 10.1007/BF00427344  0.359
1979 Izquierdo I, Beamish DG, Anisman H. Effect of an inhibitor of dopamin-beta-hydroxylase on the acquistion and retention of four different avoidance tasks in mice. Psychopharmacology. 63: 173-8. PMID 112636 DOI: 10.1007/BF00429698  0.311
1979 Sklar LS, Anisman H. Stress and coping factors influence tumor growth. Science (New York, N.Y.). 205: 513-5. PMID 109924 DOI: 10.1126/Science.109924  0.315
1979 Anisman H, Remington G, Sklar LS. Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology. 61: 107-24. PMID 108728 DOI: 10.1007/BF00426724  0.352
1979 Kokkinidis L, Irwin J, Anisman H. Shock-induced locomotor excitation following acute and chronic amphetamine treatment. Neuropharmacology. 18: 13-22. PMID 33347 DOI: 10.1016/0028-3908(79)90004-2  0.545
1978 Kokkinidis L, Anisman H. Abatement of stimulus perseveration following repeated d-amphetamine treatment: Absence of behaviorally augmented tolerance Pharmacology, Biochemistry and Behavior. 8: 557-563. PMID 566934 DOI: 10.1016/0091-3057(78)90388-X  0.335
1978 Kokkinidis L, Anisman H. Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration Psychopharmacology. 59: 285-292. PMID 104332 DOI: 10.1007/BF00426636  0.337
1978 Anisman H, DeCatanzaro D, Remington G. Escape performance following exposure to inescapable shock: Deficits in motor response maintenance Journal of Experimental Psychology: Animal Behavior Processes. 4: 197-218. DOI: 10.1037/0097-7403.4.3.197  0.306
1977 Anisman H. Time-dependent changes in activity, reactivity, and responsivity during shock: Effects of cholinergic and catecholaminergic manipulations Behavioral Biology. 21: 1-31. PMID 561602 DOI: 10.1016/S0091-6773(77)92215-5  0.308
1977 Kokkinidis L, Anisman H. Perseveration and rotational behavior elicited by d-amphetamine in a Y-maze exploratory task: Differential effects of intraperitoneal and unilateral intraventricular administration Psychopharmacology. 52: 123-128. PMID 407596 DOI: 10.1007/BF00439098  0.328
1977 Kokkinidis L, Raffler L, Anisman H. Simple and compact cannula system for mice Pharmacology, Biochemistry and Behavior. 6: 595-597. PMID 331346 DOI: 10.1016/0091-3057(77)90123-X  0.3
1976 Anisman H. Role of stimulus locale on strain differences in active avoidance after scopolamine or D-Amphetamine treatment Pharmacology, Biochemistry and Behavior. 4: 103-106. PMID 1265090 DOI: 10.1016/0091-3057(76)90182-9  0.322
1976 Anisman H, Kokkinidis L, Glazier S, Remington G. Differentiation of response biases elicited by scopolamine and d-amphetamine: effects on habituation. Behavioral Biology. 18: 401-17. PMID 1016178 DOI: 10.1016/S0091-6773(76)92407-X  0.311
1976 Remington G, Anisman H. Genetic and ontogenetic variations in locomotor activity following treatment with scopolamine or d amphetamine Developmental Psychobiology. 9: 579-585. PMID 1001843 DOI: 10.1002/Dev.420090611  0.302
1976 Anisman H. Effects of scopolamine and d-amphetamine on locomotor activity before and after shock: A diallel analysis in mice Psychopharmacology. 48: 165-173. PMID 826929 DOI: 10.1007/BF00423256  0.337
1976 Kokkinidis L, Anisman H. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task Psychopharmacology. 48: 261-270. PMID 823581 DOI: 10.1007/BF00496859  0.313
1975 Anisman H. Effects of scopolamine and d-amphetamine on one-way, shuttle and inhibitory avoidance: A diallel analysis in mice Pharmacology, Biochemistry and Behavior. 3: 1037-1042. PMID 1223892 DOI: 10.1016/0091-3057(75)90013-1  0.308
1975 Anisman H. Dissociation of disinhibitory effects of scopolamine: Strain and task factors Pharmacology, Biochemistry and Behavior. 3: 613-618. PMID 1187725 DOI: 10.1016/0091-3057(75)90182-3  0.325
1975 Anisman H. Acquisition and reversal learning of an active avoidance response in three strains of mice Behavioral Biology. 14: 51-58. PMID 1137533 DOI: 10.1016/S0091-6773(75)90314-4  0.306
1975 Anisman H. Time-dependent variations in aversively motivated behaviors: Nonassociative effects of cholinergic and catecholaminergic activity Psychological Review. 82: 359-385. PMID 170635 DOI: 10.1037/0033-295X.82.5.359  0.382
1975 Anisman H, Kokkinidis L. Effects of scopolamine, d-amphetamine and other drugs affecting catecholamines on spontaneous alternation and locomotor activity in mice Psychopharmacologia. 45: 55-63. DOI: 10.1007/BF00426210  0.342
Show low-probability matches.